about
Risk factor investigation for cardiovascular health through WHO STEPS approach in Ardabil, IranEffect of dietary intervention on serum lignan levels in pregnant women - a controlled trial.Familial melanoma by histology and age: joint data from five Nordic countries.Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer RegistriesTERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphismIncorporation of detailed family history from the Swedish Family Cancer Database into the PCPT risk calculatorA simple-to-use method incorporating genomic markers into prostate cancer risk prediction tools facilitated future validation.Diagnostic values of GHSR DNA methylation pattern in breast cancer.Correction for under-ascertainment in cancer cases in the very elderly (aged 75+): external reference method.Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study.Risk of cancer in patients with medically diagnosed hay fever or allergic rhinitis.Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries.Population Landscape of Familial Cancer.Search for familial clustering of multiple myeloma with any cancer.Familial risk of non-Hodgkin lymphoma by sex, relationship, age at diagnosis and histology: a joint study from five Nordic countries.Risk of familial classical Hodgkin lymphoma by relationship, histology, age, and sex: a joint study from five Nordic countries.Risk of thyroid cancer in relatives of patients with medullary thyroid carcinoma by age at diagnosis.Miscarriage and risk of cardiovascular disease.Idiopathic generalized epilepsies: a follow-up study in a single-center.The population impact of familial cancer, a major cause of cancer.C-reactive protein and seizures in focal epilepsy: a video-electroencephalographic study.Reproductive history and carotid intima-media thickness.The high prevalence of antiphospholipid antibodies in refractory focal epilepsy is related to recurrent seizures.Multiple primary (even in situ) melanomas in a patient pose significant risk to family members.Effect of a detailed family history of melanoma on risk for other tumors: a cohort study based on the nationwide Swedish Family-Cancer Database.Risk of subsequent cancers in renal cell carcinoma survivors with a family history.Metastatic sites and survival in lung cancer.Collection and use of family history in oncology clinics.Nonendocrine cancers associated with benign and malignant parathyroid tumors.Retention rates of new antiepileptic drugs in localization-related epilepsy: a single-center study.Risk of Next Melanoma in Patients With Familial and Sporadic Melanoma by Number of Previous Melanomas.Clinical predictors in patients with refractory epilepsy exposed to levetiracetam: a single-center study.Cardiovascular diseases attributable to hysterectomy: a population-based study.High concentration of immunoglobulin A is associated with temporal lobe epilepsy.Interleukin-6 levels are increased in temporal lobe epilepsy but not in extra-temporal lobe epilepsy.Histological concordance in familial central nervous system tumors: Evidence from nationwide Swedish Family-Cancer Database.Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries.Substantial under-estimation in cancer incidence estimates for developing countries due to under-ascertainment in elderly cancer cases.Cancer Risk in Relatives of Testicular Cancer Patients by Histology Type and Age at Diagnosis: A Joint Study from Five Nordic Countries.Nervous system tumors in adult immigrants to Sweden by subsite and histology.
P50
Q32127295-C44E2299-07B8-40CC-9C0A-13A771CF9EF4Q34220685-D9B24005-1118-4092-AE60-CE8EEA88B507Q35086070-2DDDC5CA-D5E8-492D-A733-FDE2EE97B98DQ36611288-E65182E2-A2BA-4E06-BF29-DE2B6306C032Q37256055-9E9CCDA4-E053-41BC-946F-C1AA03D69C80Q37279076-801779FC-B623-4E98-AEC3-7B5C63F1CFD0Q39038664-D63FFE8F-FA5A-4036-9C9F-DF992031907CQ39296237-AAE3B908-4C3C-4C53-A890-C2B5D2151EADQ40116347-55C33E5D-F482-4654-821D-B7E634089CADQ40198331-A8C88166-342A-4914-A8AC-F56BA992DFCDQ40212072-E8601CE1-2861-4769-B482-F5A8DD1FD806Q40593895-85C6461E-38E4-4E59-B1C5-37457D3F505CQ40643761-237D659A-DD5F-4109-9A23-43FAFBB6A094Q41245666-F918A434-BD18-4E33-84EA-9F57E1EC473DQ41255877-C7A739C2-2E1C-43DA-B69D-0DD0A5A91193Q41448655-B187BFFB-D8E7-4C31-99AA-79109C5CAA1BQ42612977-9C9805CE-2C13-44CC-B723-890DDDC7CE21Q43234568-F2F31238-2D69-4079-8018-24DB8A180CE5Q43240428-A138DC19-F9A0-4873-8454-058B75EEAD3DQ43701059-BA362713-2E0B-4D8E-A184-C259F84EC175Q43958205-DC2F9434-D99B-47A7-8A2F-365A3CC1CB60Q43995190-0FE62968-D19B-43CB-85AC-B62632D1D7DCQ44469864-8A718E54-C00A-4562-AFDA-FC5C90786FCCQ44490627-07934E46-9255-4C3C-A21A-AFE15ADAC3CCQ44828378-D18BD605-B60F-49F7-B8C2-4A70558BFF32Q45003010-D4A70F55-1A02-42C9-BF6E-739B5FCB4B1DQ45867694-5B4321A2-2CED-49F4-BFF2-1984F76F2FD3Q45868194-EFE48BE1-5784-4D1F-8E1B-8232C96A29B4Q46142330-13C2BB2C-538C-4A96-A46E-BCF9392A6DDCQ46491198-2F825CF6-8A83-4F71-8C39-A6C156133932Q46640446-F3A013FB-CBC3-4765-808F-2BE4AD886993Q46849036-837B5A8C-AA8F-47EC-BD5D-518FB6E74CDCQ46965195-323F3752-5587-41E8-9DA2-94F1E4A85F9BQ48454764-E9DDA69C-CA30-405D-9785-CEE4A97823BEQ48719793-63213AA6-E7B4-4009-A0B1-51601AF179B6Q50452756-97880518-DAD4-4C7B-99ED-425772B5D6DBQ51250971-8E0492A0-87FC-486B-8295-9F72FDEE0A0FQ53035026-0958F72E-B6E2-4EB0-B1D9-E0A2BEFB8DD2Q53529213-D64CC8C2-BCA9-47E4-878F-907D1B207312Q55463559-BC2E0F46-6EEC-4E2B-B06E-8171FCB7F374
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mahdi Fallah
@ast
Mahdi Fallah
@en
Mahdi Fallah
@es
Mahdi Fallah
@nl
Mahdi Fallah
@sl
type
label
Mahdi Fallah
@ast
Mahdi Fallah
@en
Mahdi Fallah
@es
Mahdi Fallah
@nl
Mahdi Fallah
@sl
altLabel
Dr. Mahdi Fallah
@en
prefLabel
Mahdi Fallah
@ast
Mahdi Fallah
@en
Mahdi Fallah
@es
Mahdi Fallah
@nl
Mahdi Fallah
@sl
P1053
A-8745-2008
P106
P1153
16244748100
P1960
T5i6hacAAAAJ
P21
P2798
P31
P3829
P496
0000-0002-6639-065X